Physician profile
Eric R Ernst
NPI 1437136819
$63,223.78
in general payments reported to CMS, 2019-2025
7 companies · $3,829 in 2025
The $3,829 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,402 · 2021: $9,039 · 2022: $10K · 2023: $4,247 · 2024: $12K · 2025: $3,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $986 · Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,905.00 |
| Travel and Lodging | $985.59 |
| Food and Beverage | $564.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $28,573.42 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $16,889.01 | 2019-2025 | |
| Lilly USA, LLC | $16,570.47 | 2020-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $930.00 | 2019 | |
| Abbott Laboratories | $120.03 | 2019 | |
| Impulse Dynamics (USA) INC. | $109.47 | 2024-2025 | Optimizer |
| Kestra Medical Technology Services, INC. | $31.38 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.